- Find
Breast Cancer Osteoporosis
Analysis from the Women's Health Initiative has found that women who took the bone saving drugs called bisphosphonates had fewer invasive breast cancers than women who didn't take the meds. The analysis of more than 150,000 women found that those who were taking Fosamax had 32 percent fewer cases of invasive breast cancer. Experts say further studies are needed, but they suggest that the finding may affect a woman's decision about whether she takes a bisphosphonate or not.
More information on "Breast Cancer Osteoporosis"
From Our Experts
Evista (Raloxifene), Breast Cancer and Osteoporosis
For the past few years, most physicians have routinely treated osteoporosis in the same manner. The most commonly used medication class is... Read more »
Breast Cancer and Osteoporosis: Beware the Connection
When you’re diagnosed with breast cancer, it becomes the Big Gorilla in the corner, healthwise. The sore throat, head cold, or heartburn... Read more »
Breast Cancer or Osteoporosis: Which is Worse?
There are times when, presented with two choices, your answer is “neither.” Maybe your mother gave you a choice: swallow some big... Read more »
Evista FAQs : Hormone Therapy for Breast Cancer
Q. My family history of breast cancer (both my mother and sister have had it) puts me at high risk of the disease. And now that I'm pushing... Read more »
Osteoporosis after Breast Cancer
Lila de Tantillo, an expert from our partner site OsteoporosisConnection.com, discusses osteoporosis as a side effect of breast cancer... Read more »
From Our Sources
Newer drugs boost breast cancer survival--and osteoporosis ris...
Postmenopausal breast cancer patients who switch from tamoxifen therapy to aromatase inhibitors boost their chances for survival from the disease.... Read more »
Osteoporosis med may prevent breast cancer
The osteoporosis med Evista may help prevent certain kinds of breast cancer, a new study suggests. The drug is already approved for women who are at... Read more »
FDA accepts application for new Osteoporosis med
The U.S. Food and Drug Administration (FDA) has accepted an application for the new osteoporosis medication denosumab. Drugmaker Amgen has applied to... Read more »
Menopause drug tied to breast cancer recurrence
A large study of tibolone, a drug used to treat menopausal symptoms and to prevent osteoporosis, was halted early after researchers found that the... Read more »
Early-onset osteoporosis linked to cancer risk
People who develop osteoporosis at younger ages may have a higher risk of certain cancers, researchers say. The scientists also found that people who... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
